Epidemiology of esophageal cancer: update in global trends, etiology and risk factors

DJ Uhlenhopp, EO Then, T Sunkara… - Clinical journal of …, 2020 - Springer
Esophageal cancer is the eighth most common type of cancer worldwide and constitutes the
sixth leading cause of cancer deaths. It is characterized by its high mortality rate, poor …

Update on management of squamous cell esophageal cancer

JK Waters, SI Reznik - Current oncology reports, 2022 - Springer
Abstract Purpose of the Review Esophageal cancer is the sixth most common cause of
cancer death globally. Squamous cell carcinoma of the esophagus (ESCC) is the …

Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology

JA Ajani, TA D'Amico, DJ Bentrem, D Cooke… - Journal of the National …, 2023 - jnccn.org
Cancers originating in the esophagus or esophagogastric junction constitute a major global
health problem. Esophageal cancers are histologically classified as squamous cell …

Esophageal and esophagogastric junction cancers, version 2.2019, NCCN clinical practice guidelines in oncology

JA Ajani, TA D'Amico, DJ Bentrem, J Chao… - Journal of the National …, 2019 - jnccn.org
Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide.
Squamous cell carcinoma is the most common histology in Eastern Europe and Asia, and …

Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC‐ESCC2019): a multicenter, phase 2 study

J Liu, J Li, W Lin, D Shao, L Depypere… - … Journal of Cancer, 2022 - Wiley Online Library
Optimal treatment for resectable esophageal squamous cell carcinoma (ESCC) is
controversial, especially in the context of potential benefit of combining PD‐1 blockade with …

[HTML][HTML] Integrated genomic characterization of oesophageal carcinoma

Cancer Genome Atlas Research Network - Nature, 2017 - ncbi.nlm.nih.gov
Oesophageal cancers are prominent worldwide; however, there are few targeted therapies
and survival rates for these cancers remain dismal. Here we performed a comprehensive …

[HTML][HTML] Checkpoint inhibitors for gastroesophageal cancers: dissecting heterogeneity to better understand their role in first-line and adjuvant therapy

EC Smyth, V Gambardella, A Cervantes, T Fleitas - Annals of Oncology, 2021 - Elsevier
Gastroesophageal adenocarcinoma (GEA) and squamous esophageal cancer (ESCC) are
responsible for> 1 million deaths annually globally. Until now, patients with metastatic GEA …

Esophageal and esophagogastric junction cancers, version 1.2015

JA Ajani, TA D'Amico, K Almhanna, DJ Bentrem… - Journal of the National …, 2015 - jnccn.org
Esophageal cancer is the sixth most common cause of cancer deaths worldwide.
Adenocarcinoma is more common in North America and Western European countries …

Efficacy of concurrent chemoradiotherapy with S-1 vs radiotherapy alone for older patients with esophageal cancer: a multicenter randomized phase 3 clinical trial

Y Ji, X Du, W Zhu, Y Yang, J Ma, L Zhang, J Li… - JAMA …, 2021 - jamanetwork.com
Importance Most older patients with esophageal cancer cannot complete the standard
concurrent chemoradiotherapy (CCRT). An effective and tolerable chemoradiotherapy …

[HTML][HTML] Epidemiologic differences in esophageal cancer between Asian and Western populations

HZ Zhang, GF Jin, HB Shen - Chinese journal of cancer, 2012 - ncbi.nlm.nih.gov
Esophageal cancer is a common cancer worldwide and has a poor prognosis. The
incidence of esophageal squamous cell cancer has been decreasing, whereas the …